Hormel Foods Corp (HRL) stock
Close on Oct 30, 2026Market cap $11.71BP/E 33.8Yield 5.45%
Earnings
Hormel Foods's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Hormel Foods's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Oct 26, 2026 | Dec 3, 2026Expected | – | – | – | – | – |
| Q3 FY2026ended Jul 26, 2026 | Aug 27, 2026after the close | $2.96B | -2.3% | $0.11 | $0.37 | Release |
| Q2 FY2026ended Apr 26, 2026 | May 28, 2026after the close | $2.97B | +2.4% | $0.29 | $0.40 | Release |
| Q1 FY2026ended Jan 25, 2026 | Feb 26, 2026after the close | $3.03B | +1.3% | $0.33 | $0.34 | Release |
| Q4 FY2025ended Oct 26, 2025 | Dec 4, 2025after the close | $3.20B | +3.2% | -$0.10 | $0.32 | Release |
| Q3 FY2025ended Jul 27, 2025 | Aug 28, 2025after the close | $3.03B | +4.5% | $0.33 | $0.35 | Release |
| Q2 FY2025ended Apr 27, 2025 | May 29, 2025after the close | $2.90B | +0.3% | $0.33 | $0.35 | Release |
| Q1 FY2025ended Jan 26, 2025 | Feb 27, 2025after the close | $2.99B | -0.3% | $0.31 | $0.35 | Release |
| Q4 FY2024ended Oct 27, 2024 | Dec 4, 2024after the close | $3.10B | -3.1% | $0.40 | $0.42 | Release |
| Q3 FY2024ended Jul 28, 2024 | Sep 4, 2024after the close | $2.90B | -3.3% | $0.32 | $0.37 | Release |
| Q2 FY2024ended Apr 28, 2024 | May 30, 2024after the close | $2.89B | -3.7% | $0.34 | $0.38 | Release |
| Q1 FY2024ended Jan 28, 2024 | Feb 29, 2024after the close | $3.00B | 0.0% | $0.40 | $0.41 | Release |
| Q4 FY2023ended Oct 29, 2023 | Nov 29, 2023after the close | $3.20B | -3.0% | $0.36 | $0.42 | Release |
| Q3 FY2023ended Jul 30, 2023 | Aug 31, 2023before the open | $3.00B | 0.0% | $0.30 | $0.40 | Release |
| Q2 FY2023ended Apr 30, 2023 | Jun 1, 2023before the open | $3.00B | -3.2% | $0.40 | – | Release |
| Q1 FY2023ended Jan 29, 2023 | Mar 2, 2023before the open | $3.00B | 0.0% | $0.40 | – | Release |
| Q4 FY2022ended Oct 30, 2022 | Nov 30, 2022before the open | $3.30B | -5.7% | $0.51 | – | Release |
| Q3 FY2022ended Jul 31, 2022 | Sep 1, 2022before the open | $3.00B | – | $0.40 | – | Release |
| Q2 FY2022ended May 1, 2022 | Jun 2, 2022before the open | $3.10B | – | $0.48 | – | Release |
| Q1 FY2022ended Jan 30, 2022 | Mar 1, 2022before the open | $3.00B | – | $0.44 | – | Release |
| Q4 FY2021ended Oct 31, 2021 | Dec 9, 2021before the open | $3.50B | – | $0.51 | – | Release |
| Q3 FY2021ended Jul 25, 2021 | Sep 2, 2021before the open | – | – | – | – | Filing |
| Q2 FY2021ended Apr 25, 2021 | May 20, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Jan 24, 2021 | Feb 18, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Oct 25, 2020 | Nov 24, 2020before the open | – | – | – | – | Release |
| Q3 FY2020ended Jul 26, 2020 | Aug 25, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Hormel Foods's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net salesGAAP | FY2026 | $12.10B – $12.20B | $12.20B – $12.50B | Lowered | Aug 26, 2026 |
| net salesGAAP | FY2026 | $12.20B – $12.50B | $12.20B – $12.50B | Reaffirmed | Feb 25, 2026 |
| organic net sales 1 growthnon-GAAP | FY2026 | +1% – +4% | +1% – +4% | Reaffirmed | Feb 25, 2026 |
| organic net sales growthnon-GAAP | FY2026 | +1% – +2% | +1% – +4% | Lowered | Aug 26, 2026 |
| adjusted operating incomenon-GAAP | FY2026 | $1.08B – $1.12B | $1.06B – $1.12B | Raised | Aug 26, 2026 |
| adjusted operating incomenon-GAAP | FY2026 | $1.06B – $1.12B | $1.06B – $1.12B | Reaffirmed | Feb 25, 2026 |
| operating incomeGAAP | FY2026 | $830.00M – $870.00M | $960.00M – $1.02B | Lowered | Aug 26, 2026 |
| operating incomeGAAP | FY2026 | $1.02B – $1.08B | $960.00M – $1.03B | Raised | Feb 25, 2026 |
| diluted earnings per shareGAAP | FY2026 | $1.06 – $1.12 | $1.28 – $1.37 | Lowered | Aug 26, 2026 |
| diluted earnings per shareGAAP | FY2026 | $1.37 – $1.46 | $1.29 – $1.39 | Raised | Feb 25, 2026 |
| adjusted diluted earnings per sharenon-GAAP | FY2026 | $1.45 – $1.51 | $1.43 – $1.51 | Raised | Aug 26, 2026 |
| adjusted diluted earnings per sharenon-GAAP | FY2026 | $1.43 – $1.51 | $1.43 – $1.51 | Reaffirmed | Feb 25, 2026 |
| Capital expenditures | FY2026 | $260.00M – $290.00M | – | New | Dec 3, 2025 |
| adjusted diluted earnings per share growthnon-GAAP | FY2026 | +6% – +10% | – | Reaffirmed | Aug 26, 2026 |
| adjusted operating income growthnon-GAAP | FY2026 | +6% – +10% | – | New | Aug 26, 2026 |
| Depreciation and amortization expense | FY2026 | $280.00M | – | New | Dec 3, 2025 |
| effective tax rate | FY2026 | 21.5% – 22.5% | – | New | Dec 3, 2025 |
Guidance vs results
The last range Hormel Foods gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2023 | Revenue | $3.10B – $3.60B | $3.20B | Within range |
Guidance history
Every forecast Hormel Foods put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 26, 2026 | adjusted diluted earnings per share | FY2026 | $1.45 – $1.51 | Raised |
| Aug 26, 2026 | diluted earnings per share | FY2026 | $1.06 – $1.12 | Lowered |
| Aug 26, 2026 | operating income | FY2026 | $830.00M – $870.00M | Lowered |
| Aug 26, 2026 | adjusted operating income | FY2026 | $1.08B – $1.12B | Raised |
| Aug 26, 2026 | adjusted operating income growth | FY2026 | +6% – +10% | New |
| Aug 26, 2026 | adjusted diluted earnings per share growth | FY2026 | +6% – +10% | Reaffirmed |
| Aug 26, 2026 | organic net sales growth | FY2026 | +1% – +2% | Lowered |
| Aug 26, 2026 | net sales | FY2026 | $12.10B – $12.20B | Lowered |
| May 27, 2026 | adjusted diluted earnings per share | FY2026 | $1.43 – $1.51 | New |
| May 27, 2026 | diluted earnings per share | FY2026 | $1.28 – $1.37 | New |
| May 27, 2026 | operating income | FY2026 | $960.00M – $1.02B | New |
| May 27, 2026 | adjusted operating income | FY2026 | $1.06B – $1.12B | New |
| May 27, 2026 | organic net sales growth | FY2026 | +1% – +4% | New |
| May 27, 2026 | net sales | FY2026 | $12.20B – $12.50B | New |
| Feb 25, 2026 | adjusted diluted earnings per share | FY2026 | $1.43 – $1.51 | Reaffirmed |
| Feb 25, 2026 | diluted earnings per share | FY2026 | $1.37 – $1.46 | Raised |
| Feb 25, 2026 | operating income | FY2026 | $1.02B – $1.08B | Raised |
| Feb 25, 2026 | adjusted operating income | FY2026 | $1.06B – $1.12B | Reaffirmed |
| Feb 25, 2026 | organic net sales 1 growth | FY2026 | +1% – +4% | Reaffirmed |
| Feb 25, 2026 | net sales | FY2026 | $12.20B – $12.50B | Reaffirmed |
| Dec 3, 2025 | Capital expenditures | FY2026 | $260.00M – $290.00M | New |
| Dec 3, 2025 | Adjusted diluted earnings per share | FY2026 | $1.43 – $1.51 | New |
| Dec 3, 2025 | Diluted earnings per share | FY2026 | $1.29 – $1.39 | New |
| Dec 3, 2025 | Operating income | FY2026 | $960.00M – $1.03B | New |
| Dec 3, 2025 | Adjusted operating income | FY2026 | $1.06B – $1.12B | New |
| Dec 3, 2025 | effective tax rate | FY2026 | 21.5% – 22.5% | New |
| Dec 3, 2025 | Depreciation and amortization expense | FY2026 | $280.00M | New |
| Dec 3, 2025 | organic net sales 1 growth | FY2026 | +1% – +4% | New |
| Dec 3, 2025 | Net sales | FY2026 | $12.20B – $12.50B | New |
| Aug 27, 2025 | Capital expenditures | FY2025 | $300.00M | New |
| Aug 27, 2025 | effective tax rate | FY2025 | 22% | New |
| Aug 27, 2025 | Depreciation and amortization expense | FY2025 | $260.00M | New |
| May 28, 2025 | capital expenditures | FY2025 | $275.00M – $300.00M | Reaffirmed |
| May 28, 2025 | adjusted diluted earnings per share | FY2025 | $1.58 – $1.68 | Lowered |
| May 28, 2025 | diluted earnings per share | FY2025 | $1.49 – $1.59 | Lowered |
| May 28, 2025 | Operating Income (GAAP) | FY2025 | $1.12B – $1.19B | Lowered |
| May 28, 2025 | Adjusted Operating Income (Non-GAAP) | FY2025 | $1.18B – $1.25B | Lowered |
| May 28, 2025 | effective tax rate | FY2025 | 22% – 23% | Reaffirmed |
| May 28, 2025 | T&M benefits | FY2025 | $100.00M – $150.00M | Lowered |
| May 28, 2025 | Depreciation and amortization expense | FY2025 | $265.00M | Raised |
| May 28, 2025 | organic net sales growth | FY2025 | +2% – +3% | Raised |
| May 28, 2025 | Net Sales | FY2025 | $12.00B – $12.20B | Raised |
| Feb 26, 2025 | capital expenditures | FY2025 | $275.00M – $300.00M | Reaffirmed |
| Feb 26, 2025 | adjusted diluted earnings per share | FY2025 | $1.58 – $1.72 | Reaffirmed |
| Feb 26, 2025 | diluted earnings per share | FY2025 | $1.49 – $1.63 | Lowered |
| Feb 26, 2025 | organic net sales | FY2025 | +1% – +3% | Reaffirmed |
| Dec 3, 2024 | capital expenditures | FY2025 | $275.00M – $300.00M | New |
| Dec 3, 2024 | Adjusted diluted earnings per share | FY2025 | $1.58 – $1.72 | New |
| Dec 3, 2024 | Diluted earnings per share | FY2025 | $1.51 – $1.65 | New |
| Dec 3, 2024 | Operating income | FY2025 | $1.13B – $1.23B | New |
| Dec 3, 2024 | Adjusted operating income | FY2025 | $1.18B – $1.28B | New |
| Dec 3, 2024 | Effective Tax Rate | FY2025 | 22% – 23% | New |
| Dec 3, 2024 | Depreciation and amortization expense | FY2025 | $265.00M | New |
| Dec 3, 2024 | organic net sales | FY2025 | +1% – +3% | New |
| Dec 3, 2024 | Net sales | FY2025 | $11.90B – $12.20B | New |
| Sep 3, 2024 | capital expenditures | FY2024 | $280.00M | Reaffirmed |
| Sep 3, 2024 | adjusted diluted net earnings per share | FY2024 | $1.57 – $1.63 | Narrowed |
| Sep 3, 2024 | diluted net earnings per share | FY2024 | $1.45 – $1.51 | Lowered |
| Sep 3, 2024 | effective tax rate | FY2024 | 22% – 23% | Reaffirmed |
| Sep 3, 2024 | full-year expense | FY2024 | $250.00M | Reaffirmed |
| Sep 3, 2024 | net sales | FY2024 | $11.80B – $12.10B | Lowered |
| May 29, 2024 | capital expenditures | FY2024 | $280.00M | Reaffirmed |
| May 29, 2024 | adjusted diluted net earnings per share | FY2024 | $1.55 – $1.65 | Raised |
| May 29, 2024 | diluted net earnings per share | FY2024 | $1.45 – $1.55 | Narrowed |
| May 29, 2024 | Effective Tax Rate | FY2024 | 22% – 23% | Raised |
| May 29, 2024 | depreciation and amortization expense | FY2024 | $250.00M | Reaffirmed |
| May 29, 2024 | net sales growth outlook | FY2024 | +1% – +3% | New |
| May 29, 2024 | Net Sales | FY2024 | $12.20B – $12.50B | Reaffirmed |
| Feb 28, 2024 | capital expenditures | FY2024 | $280.00M | Reaffirmed |
| Feb 28, 2024 | adjusted diluted net earnings per share | FY2024 | $1.51 – $1.65 | Reaffirmed |
| Feb 28, 2024 | diluted net earnings per share | FY2024 | $1.43 – $1.57 | Reaffirmed |
| Feb 28, 2024 | Depreciation and amortization expense | FY2024 | $250.00M | Reaffirmed |
| Feb 28, 2024 | Effective Tax Rate | FY2024 | 21% – 23% | Reaffirmed |
| Feb 28, 2024 | Net Sales | FY2024 | $12.20B – $12.50B | Reaffirmed |
| Nov 29, 2023 | capital expenditures | FY2024 | $280.00M | New |
| Nov 29, 2023 | adjusted diluted net earnings per share | FY2024 | $1.51 – $1.65 | New |
| Nov 29, 2023 | Diluted net earnings per share | FY2024 | $1.43 – $1.57 | New |
| Nov 29, 2023 | Effective Tax Rate | FY2024 | 21% – 23% | New |
| Nov 29, 2023 | Net sales growth | FY2024 | +1% – +3% | New |
| Nov 29, 2023 | full-year expense | FY2024 | $250.00M | New |
| Nov 29, 2023 | Net Sales | FY2024 | $12.20B – $12.50B | New |
| Aug 31, 2023 | capital expenditures | FY2023 | $280.00M | Reaffirmed |
| Aug 31, 2023 | adjusted diluted net earnings per share | FY2023 | $1.61 – $1.67 | New |
| Aug 31, 2023 | diluted net earnings per share | FY2023 | $1.51 – $1.57 | Lowered |
| Aug 31, 2023 | Depreciation and amortization expense | FY2023 | $285.00M | Reaffirmed |
| Aug 31, 2023 | effective tax rate | FY2023 | 21% – 23% | Reaffirmed |
| Aug 31, 2023 | net sales | Q4 FY2023 | $3.10B – $3.60B | New |
| Jun 1, 2023 | capital expenditures | FY2023 | $280.00M | Lowered |
| Jun 1, 2023 | diluted net earnings per share | FY2023 | $1.70 – $1.82 | Reaffirmed |
| Jun 1, 2023 | effective tax rate | FY2023 | 21% – 23% | Reaffirmed |
| Jun 1, 2023 | full-year expense | FY2023 | $285.00M | Reaffirmed |
| Jun 1, 2023 | net sales growth | FY2023 | +1% – +3% | New |
| Mar 2, 2023 | capital expenditures | FY2023 | $350.00M | Reaffirmed |
| Mar 2, 2023 | diluted net earnings per share | FY2023 | $1.70 – $1.82 | Lowered |
| Mar 2, 2023 | effective tax rate | FY2023 | 21% – 23% | New |
| Mar 2, 2023 | depreciation and amortization expense | FY2023 | $285.00M | New |
| Mar 2, 2023 | net sales growth | FY2023 | +1% – +3% | New |
| Nov 30, 2022 | Capital Expenditures | FY2023 | $350.00M | New |
| Nov 30, 2022 | Diluted Earnings per Share | FY2023 | $1.83 – $1.93 | New |
| Nov 30, 2022 | Effective Tax Rate | FY2023 | 21% – 23% | New |
| Nov 30, 2022 | Depreciation and Amortization | FY2023 | $285.00M | New |
| Nov 30, 2022 | Net Sales | FY2023 | $12.60B – $12.90B | New |
| Sep 1, 2022 | capital expenditures | FY2022 | $310.00M | Reaffirmed |
| Sep 1, 2022 | Diluted Earnings per Share Guidance | FY2022 | $1.78 – $1.85 | Lowered |
| Sep 1, 2022 | effective tax rate | FY2022 | 20.5% – 22.5% | Reaffirmed |
| Sep 1, 2022 | full-year expense | FY2022 | $250.00M | Reaffirmed |
| Sep 1, 2022 | Net Sales Guidance (in billions) | FY2022 | $12.20B – $12.80B | Raised |
| Jun 2, 2022 | capital expenditures | FY2022 | $310.00M | Reaffirmed |
| Jun 2, 2022 | Diluted Earnings per Share Guidance | FY2022 | $1.87 – $1.97 | Lowered |
| Jun 2, 2022 | effective tax rate | FY2022 | 20.5% – 22.5% | Reaffirmed |
| Jun 2, 2022 | Depreciation and amortization expense | FY2022 | $250.00M | Reaffirmed |
| Jun 2, 2022 | Net Sales Guidance (in billions) | FY2022 | $11.70B – $12.50B | Reaffirmed |
| Mar 1, 2022 | capital expenditures | FY2022 | $310.00M | Reaffirmed |
| Mar 1, 2022 | Diluted Earnings per Share Guidance | FY2022 | $1.87 – $2.03 | New |
| Mar 1, 2022 | effective tax rate | FY2022 | 20.5% – 22.5% | Reaffirmed |
| Mar 1, 2022 | Depreciation and amortization expense | FY2022 | $250.00M | Reaffirmed |
| Mar 1, 2022 | Net Sales Guidance (in billions) | FY2022 | $11.70B – $12.50B | Reaffirmed |
| Dec 9, 2021 | capital expenditures | FY2022 | $310.00M | New |
| Dec 9, 2021 | Diluted Earnings per Share Guidance | FY2022 | $1.87 – $2.03 | New |
| Dec 9, 2021 | effective tax rate | FY2022 | 20.5% – 22.5% | New |
| Dec 9, 2021 | Depreciation and amortization expense | FY2022 | $250.00M | New |
| Dec 9, 2021 | Net Sales Guidance | FY2022 | $11.70B – $12.50B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Hormel Foods filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Update
- Update
- Results
- Results